leflunomide has been researched along with diallyl disulfide in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abass, SA; Abdel-Hamid, NM; Abdel-Kareem, MA; Eldomany, RA; Zakaria, S | 1 |
1 other study(ies) available for leflunomide and diallyl disulfide
| Article | Year |
|---|---|
Dual regulating of mitochondrial fusion and Timp-3 by leflunomide and diallyl disulfide combination suppresses diethylnitrosamine-induced hepatocellular tumorigenesis in rats.
Topics: Alkylating Agents; Allyl Compounds; Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Diethylnitrosamine; Disulfides; Drug Therapy, Combination; Gene Expression Regulation, Neoplastic; Immunosuppressive Agents; Leflunomide; Liver Neoplasms, Experimental; Male; Mitochondrial Dynamics; Rats; Rats, Wistar; Tissue Inhibitor of Metalloproteinase-3 | 2022 |